ORCHESTRATING THE IMMUNE SYSTEM Trademark

Trademark Overview

On Monday, July 25, 2022, a trademark application was filed for ORCHESTRATING THE IMMUNE SYSTEM with the United States Patent and Trademark Office. The USPTO has given the ORCHESTRATING THE IMMUNE SYSTEM trademark a serial number of 97518230. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, October 23, 2024. This trademark is owned by Mozart Therapeutics, Inc.. The ORCHESTRATING THE IMMUNE SYSTEM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders; biological products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastro...
orchestrating the immune system

General Information

Serial Number97518230
Word MarkORCHESTRATING THE IMMUNE SYSTEM
Filing DateMonday, July 25, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, October 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders; biological products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic products, namely, preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; pharmaceutical products and preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; biological products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; cell therapy products, namely preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; therapeutic and medicinal products, namely, preparations for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, and cancer; diagnostic biomarker reagents for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, and cancer; diagnostic agents, preparations, and substances for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, and gastrointestinal diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMozart Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameMozart Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events

Event DateEvent Description
Thursday, July 28, 2022NEW APPLICATION ENTERED
Thursday, July 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 10, 2023ASSIGNED TO EXAMINER
Thursday, June 1, 2023NON-FINAL ACTION WRITTEN
Thursday, June 1, 2023NON-FINAL ACTION E-MAILED
Thursday, June 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 5, 2024SOU EXTENSION 1 GRANTED
Tuesday, March 5, 2024SOU EXTENSION 1 FILED
Wednesday, October 23, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2024SOU EXTENSION 2 GRANTED
Wednesday, October 23, 2024SOU EXTENSION 2 FILED
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

system immune orchestrating disorders diseases namely inflammatory autoimmune products treatment preparations prevention gastrointestinal